When is it usually re-screened?
To begin with, it must be said that for the first time a woman undergoes such a study at a very short time, 12-13 weeks. At this time, doctors manage to establish violations in the development of organs and systems. If we talk about how many weeks do the 2 screening, then the optimal time for it is 16-20 weeks. Usually it is prescribed in the interval of 17-19 weeks. It is these terms that doctors call when answering the question of expectant mothers about how many weeks during pregnancy they make a second screening.
What is the purpose of this study and what does it allow to establish?
Screening allows you to identify among women at risk of developing a chromosomal abnormality in their baby. In this case, such a procedure is always complex and includes ultrasound, a biochemical blood test. It is during the last survey that certain markers are established, among them: alpha-fetoprotein (AFP) , free estriol, human chorionic gonadotropin (hCG). In this regard, quite often from physicians you can hear the second name - triple test.
The establishment of a concentration in the blood of a pregnant woman of the substances listed above makes it possible to speak with high probability of an increased risk of the formation of such pathologies as:
- Down's syndrome (the second name is trisomy 21);
- Edwards' syndrome (trisomy 18);
- defects of the neural tube (spinal cord and anencephaly free, no brain).
How is the interpretation of the results obtained?
Having dealt with the number of weeks in which 2 screening is done, we will describe how the results are evaluated.
To begin with, it is necessary to say that only a doctor can do this. After all, changing a particular indicator is not a direct violation, but only indicates the likelihood of its development.
For example, an increase in the concentration of hCG in the blood of a future mother may indicate a greater likelihood of developing chromosomal abnormalities in a future baby, the possibility of gestosis. The decrease in the level of this hormone, as a rule, indicates a violation of the development of the placenta.
The discrepancy between the concentration of AFP in the blood serum of a future mother is regarded as a sign of a violation of the number of chromosomes, the genome of the future baby. Possible diseases that develop in this case are listed above. It should be noted that a sharp increase in the concentration of alpha-fetoprotein can cause fetal death.
Thus, as can be seen from the article, screening refers to those studies that can only indicate the possibility of developing a particular pathology. Therefore, always after the evaluation of the results and the presence of suspicions, additional diagnostics are prescribed.